Multiple sclerosis (MS) can be divided into four phenotypes based on clinical evolution. The pathophysiological boundaries of these phenotypes are unclear, limiting treatment stratification. Machine learning can identify groups with similar features using multidimensional data. Here, to classify MS subtypes based on pathological features, we apply unsupervised machine learning to brain MRI scans acquired in previously published studies. We use a training dataset from 6322 MS patients to define MRI-based subtypes and an independent cohort of 3068 patients for validation. Based on the earliest abnormalities, we define MS subtypes as cortex-led, normal-appearing white matter-led, and lesion-led. People with the lesion-led subtype have the high...
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning...
Background and purpose: Subtyping relapsing–remitting multiple sclerosis (RRMS) patients may help pr...
BACKGROUND AND PURPOSE: Conventional MR imaging explains only a fraction of the clinical outcome var...
Multiple sclerosis (MS) can be divided into four phenotypes based on clinical evolution. The pathoph...
Multiple sclerosis (MS) can be divided into four phenotypes based on clinical evolution. The pathoph...
Objectives: To stratify patients with multiple sclerosis (pwMS) based on brain MRI-derived volumetri...
Objectives: To evaluate the accuracy of a data-driven approach, such as machine learning classificat...
International audiencePurpose: The purpose of this study is classifying multiple sclerosis (MS) pati...
OBJECTIVE:To explore the value of machine learning methods for predicting multiple sclerosis disease...
To explore the value of machine learning methods for predicting multiple sclerosis disease course.16...
Purpose: The purpose of this study is classifying multiple sclerosis (MS) patients in the four clini...
Background: Disease heterogeneity is a major issue in multiple sclerosis (MS). Classification of MS ...
Background: While disease categories (i.e. clinical phenotypes) of multiple sclerosis (MS) are estab...
AbstractBackgroundWhile disease categories (i.e. clinical phenotypes) of multiple sclerosis (MS) are...
Motor disability is a dominant and restricting symptom in multiple sclerosis, yet its neuroimaging c...
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning...
Background and purpose: Subtyping relapsing–remitting multiple sclerosis (RRMS) patients may help pr...
BACKGROUND AND PURPOSE: Conventional MR imaging explains only a fraction of the clinical outcome var...
Multiple sclerosis (MS) can be divided into four phenotypes based on clinical evolution. The pathoph...
Multiple sclerosis (MS) can be divided into four phenotypes based on clinical evolution. The pathoph...
Objectives: To stratify patients with multiple sclerosis (pwMS) based on brain MRI-derived volumetri...
Objectives: To evaluate the accuracy of a data-driven approach, such as machine learning classificat...
International audiencePurpose: The purpose of this study is classifying multiple sclerosis (MS) pati...
OBJECTIVE:To explore the value of machine learning methods for predicting multiple sclerosis disease...
To explore the value of machine learning methods for predicting multiple sclerosis disease course.16...
Purpose: The purpose of this study is classifying multiple sclerosis (MS) patients in the four clini...
Background: Disease heterogeneity is a major issue in multiple sclerosis (MS). Classification of MS ...
Background: While disease categories (i.e. clinical phenotypes) of multiple sclerosis (MS) are estab...
AbstractBackgroundWhile disease categories (i.e. clinical phenotypes) of multiple sclerosis (MS) are...
Motor disability is a dominant and restricting symptom in multiple sclerosis, yet its neuroimaging c...
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning...
Background and purpose: Subtyping relapsing–remitting multiple sclerosis (RRMS) patients may help pr...
BACKGROUND AND PURPOSE: Conventional MR imaging explains only a fraction of the clinical outcome var...